» Articles » PMID: 37539197

Proteomics Reveals Defective Peroxisomal Fatty Acid Oxidation During the Progression of Acute Kidney Injury and Repair

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Aug 4
PMID 37539197
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is characterized by a rapid decrease in renal function with high mortality and risk of progression to chronic kidney disease (CKD). Ischemia and reperfusion injury (IRI) is one of the major causes of AKI. However, the cellular and molecular responses of the kidney to IRI are complex and not fully understood. Herein, we conducted unbiased proteomics and bioinformatics analyses in an IRI mouse model on days 3, 7, and 21, and validated the results using IRI, unilateral ureteral obstruction (UUO), and biopsies from patients with AKI or CKD. The results indicated an obvious temporal expression profile of differentially expressed proteins and highlighted impaired lipid metabolism during the progression of AKI to CKD. Acyl-coenzyme A oxidase 1 (Acox1), the first rate-limiting enzyme of peroxisomal fatty acid beta-oxidation, was then selected, and its disturbed expression in the two murine models validated the proteomic findings. Accordingly, Acox1 expression was significantly downregulated in renal biopsies from patients with AKI or CKD, and its expression was negatively correlated with kidney injury score. Furthermore, in contrast to the decreased Acox1 expression, lipid droplet accumulation was remarkably increased in these renal tissues, suggesting dysregulation of fatty acid oxidation. In conclusion, our results suggest that defective peroxisomal fatty acid oxidation might be a common pathological feature in the transition from AKI to CKD, and that Acox1 is a promising intervention target for kidney injury and repair.

Citing Articles

Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression.

Jin R, Dai Y, Wang Z, Hu Q, Zhang C, Gao H Biology (Basel). 2025; 14(1).

PMID: 39857243 PMC: 11763183. DOI: 10.3390/biology14010012.


Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury.

Zhang X, Wu W, Li Y, Peng Z Ren Fail. 2024; 46(2):2403652.

PMID: 39319697 PMC: 11425701. DOI: 10.1080/0886022X.2024.2403652.


The metabolic pathway regulation in kidney injury and repair.

Tang W, Wei Q Front Physiol. 2024; 14:1344271.

PMID: 38283280 PMC: 10811252. DOI: 10.3389/fphys.2023.1344271.

References
1.
Sato Y, Takahashi M, Yanagita M . Pathophysiology of AKI to CKD progression. Semin Nephrol. 2020; 40(2):206-215. DOI: 10.1016/j.semnephrol.2020.01.011. View

2.
Palevsky P, Zhang J, OConnor T, Chertow G, Crowley S, Choudhury D . Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359(1):7-20. PMC: 2574780. DOI: 10.1056/NEJMoa0802639. View

3.
Rewa O, Bagshaw S . Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014; 10(4):193-207. DOI: 10.1038/nrneph.2013.282. View

4.
Chang-Panesso M, Kadyrov F, Lalli M, Wu H, Ikeda S, Kefaloyianni E . FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. J Clin Invest. 2019; 129(12):5501-5517. PMC: 6877314. DOI: 10.1172/JCI125519. View

5.
Griffin E, Ackerman S . Lipid Metabolism and Axon Degeneration: An ACOX1 Balancing Act. Neuron. 2020; 106(4):551-553. DOI: 10.1016/j.neuron.2020.04.030. View